LOS ANGELES, CA--(Marketwire - May 12, 2008) - Clearant, Inc. (OTCBB: CLRA), owner of the Clearant Process® designed to substantially reduce all types of pathogens in biological products including HIV, today announced that preliminary revenues for the 1st quarter period ending March 31, 2008 increased 46% to $0.47 million compared to $0.32 million in the 4th quarter 2007.
